Tuesday, December 30, 2014
FDA Approves BioCryst Flu Treatment
Durham's biotech company BioCryst has had its flu treatment, RAPIVAB approved by the FDA.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment